FOXO3 rs2883881: Longevity and Exceptional Survival
The genetic variant rs2883881 is a single nucleotide polymorphism located within the non-coding promoter/intronic region of the FOXO3 gene. Scientific studies have identified moderate statistical associations between specific alleles of this variant and exceptional human survival into nonagenarian and centenarian age brackets. While promising for our understanding of aging biology, this variant is only one small contributor within a complex polygenic and environmental landscape.
What each genotype means
Associated with exceptional longevity
This genotype is frequently identified in studies of centenarians and long-lived individuals as being associated with a higher probability of exceptional survival. Research suggests it may help mitigate mortality risks, particularly in individuals managing cardiometabolic conditions, though these associations are statistical and do not guarantee health outcomes.
This genotype is common in many populations, with the minor allele frequency for this variant reported at approximately 0.42 in Europeans and 0.48 in South Asians.
Potential longevity-associated profile
Carrying one copy of the longevity-associated allele may provide some of the protective benefits observed in studies of long-lived populations. The impact of this genotype on lifespan is generally considered intermediate compared to those who are homozygous for the longevity-associated allele.
This heterozygous genotype is found in a significant portion of the population, consistent with the observed minor allele frequencies in European and South Asian cohorts.
Baseline longevity profile
This genotype represents the more common variant in many populations and is considered the baseline in the context of longevity research. While it does not carry the specific longevity-associated signature identified in centenarian studies, it is a normal genetic variation found in the vast majority of the healthy population.
This is a common genotype, occurring frequently across diverse global populations.
Genetic Architecture and Location of rs2883881
The rs2883881 variant is situated within chromosome 6, nestled inside the non-coding regulatory architecture of the Forkhead box O-3 (FOXO3) gene. Unlike coding variants that alter the amino acid sequence of a protein, non-coding SNPs like rs2883881 are typically located in promoters, introns, or intergenic flanking regions. In these positions, they often influence how genes are regulated, modifying transcription factor binding affinity, chromatin accessibility, or RNA transcription rates. Genetic studies focused on human longevity have repeatedly tracked markers across the FOXO3 locus, where broad blocks of linkage disequilibrium mean that several neighboring SNPs are inherited together. As a result, rs2883881 frequently acts as a tag marker for regulatory haplotypes that govern the expression of FOXO3 in human tissues. Extensive sequencing efforts in longevity cohorts have demonstrated that common non-coding variations, rather than rare missense alterations, account for the robust association signals observed between the FOXO3 locus and prolonged human survival.
The Biological Role of the FOXO3 Transcription Factor
The FOXO3 gene encodes a conserved member of the forkhead family of transcription factors, which act as master regulators of cellular homeostasis, stress resistance, and metabolic adaptation. Downstream of insulin and insulin-like growth factor 1 (IGF-1) signaling cascades, FOXO3 orchestrates transcriptional programs that manage oxidative stress detoxification, DNA damage repair, autophagy, proteostasis, and cell cycle arrest. When cells face nutrient deprivation or oxidative challenge, FOXO3 translocates to the nucleus to induce genes that neutralize reactive oxygen species and recycle damaged organelles. Furthermore, FOXO3 is critical for adult stem cell maintenance and the modulation of systemic inflammatory responses. By suppressing excessive pro-inflammatory cytokine cascades and maintaining cellular self-renewal capacity, functional FOXO3 signaling shields tissues from the progressive degradation typical of biological aging. Along with APOE, FOXO3 represents one of the most consistently replicated genetic loci associated with human lifespan across global cohorts.
Research Evidence in Exceptional Longevity Cohorts
The statistical connection between FOXO3 and human lifespan was initially brought to light in cohorts of Japanese-American long-lived men and was subsequently replicated across independent populations, including large-scale European studies of nonagenarians and centenarians. Investigators conducting haplotype-tagging and candidate gene analyses evaluated multiple non-coding markers spanning FOXO3, including rs2883881, discovering an enrichment of protective alleles in oldest-old individuals compared to younger control groups. In German, Italian, and wider European longevity cohorts, the frequency of beneficial alleles at FOXO3 markers steadily increases when comparing septuagenarians to nonagenarians, with the highest enrichment observed in centenarians aged 100 and above. The evidence strength for rs2883881 is classified as moderate; while the overall FOXO3 locus is definitively linked to healthy aging, individual tag SNPs exhibit modest odds ratios. Longevity is a polygenic trait where no single genetic variant dictates exceptional survival on its own.
Population Distribution and Genetic Context
Allele frequencies for rs2883881 show significant variation across global populations, reflecting distinct ancestral demographic histories and regional linkage structures. According to data from the Genome Aggregation Database (gnomAD), the minor allele frequency is approximately 0.42 in individuals of European ancestry and reaches around 0.48 among South Asian populations. Because the variant alleles are common across continental groups, millions of individuals worldwide carry one or two copies of the longevity-associated allele. However, because longevity studies often observe ancestry-specific haplotype architectures, an allele correlated with survival in a European or East Asian cohort may not carry an identical effect size or significance in populations with different genetic backgrounds. Researchers emphasize that linkage disequilibrium patterns vary globally, making it essential to evaluate FOXO3 regulatory signals in diverse ancestral cohorts rather than generalizing findings from single-ancestry nonagenarian cohorts.
Translating Longevity Genetics to Daily Life
Finding a longevity-associated genotype in personal genetic data is an intriguing biological insight, but it is not a deterministic guarantee of lifespan. Inheriting one or two beneficial alleles at rs2883881 does not make someone immune to chronic illness, nor does lacking these alleles prevent someone from living a long, vibrant life. Complex traits like lifespan and healthspan are shaped by thousands of small-effect genetic variants interacting alongside diet, physical activity, sleep, medical care, and socioeconomic circumstances. Clinical genetic testing does not use rs2883881 for diagnostic, prognostic, or treatment choices. Rather than seeking out specific interventions based on this marker, individuals should focus on evidence-based lifestyle habits—such as regular exercise, balanced nutrition, cardiovascular health maintenance, and avoiding smoking—that reliably support cellular health and longevity regardless of individual genetic background.
How common is this variant?
The minor allele frequency for rs2883881 is approximately 0.42 in European populations and 0.48 in South Asian populations according to gnomAD, demonstrating that both alleles are widely distributed across diverse human groups.
Frequently asked questions
Does having the FOXO3 rs2883881 longevity allele mean I will live to 100?
No, carrying a longevity-associated allele does not guarantee a long life. Exceptional survival is an intricate trait influenced by thousands of genes, environmental exposures, access to healthcare, and daily health habits. Variants like rs2883881 provide only a modest statistical shift in odds within large population studies.
What role does the FOXO3 gene play in healthy aging?
FOXO3 acts as a master transcription factor that orchestrates cellular defense mechanisms, including DNA repair, antioxidant production, autophagy, and stem cell protection. Proper regulation of these pathways helps cells withstand metabolic and environmental stresses over decades of life.
Can a medical doctor use rs2883881 to make health decisions?
No, clinical guidelines do not utilize rs2883881 for medical diagnostics, risk prediction, or prescribing decisions. This variant is evaluated primarily in observational longevity research and does not have direct clinical utility for individual patient care.
Why is the evidence for rs2883881 rated as moderate?
While the FOXO3 locus is one of the most well-validated longevity regions in humans, individual tag SNPs such as rs2883881 exert relatively small individual effects. Additionally, exact effect sizes and linkage disequilibrium patterns can vary across different ancestral populations.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2883881?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FOXO3
Functional non-coding variant in the key longevity regulator FOXO3 contributing to extended survival and healthspan.
Well-characterized non-headline FOXO3 variant associated with healthy aging, lower cardiovascular mortality, and survival beyond age 90.
Non-coding FOXO3 variant identified in longitudinal aging studies as conferring an advantage for survival from midlife into advanced old age.
Common upstream intronic regulatory variant in FOXO3 correlated with human longevity and enhanced resilience against metabolic disease.
An intronic variant in the FOXO3 gene consistently associated with human longevity and survival to extreme old age across multiple ethnic cohorts.
Intronic variant in FOXO3 significantly associated with exceptional longevity and survival to advanced old age, showing allele-dependent enhancer activity.